Home/Filings/4/0001193125-26-010889
4//SEC Filing

Heery Christopher 4

Accession 0001193125-26-010889

CIK 0001786205other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 9:32 PM ET

Size

6.7 KB

Accession

0001193125-26-010889

Insider Transaction Report

Form 4
Period: 2026-01-12
Heery Christopher
CHIEF MEDICAL OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-01-02+13,02113,615 total
  • Sale

    Common Stock

    [F2][F3]
    2026-01-12$64.15/sh6,131$393,28637,068 total
Footnotes (3)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Vesting of these RSUs previously reported in the Form 4 filed January 6, 2026.
  • [F2]Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units.
  • [F3]Represents the weighted average share price of an aggregate total of 6,131 shares sold in the price range of $64.14112 to $64.4463 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Signature
/s/ Michelle Gilson, as Attorney-in-Fact|2026-01-12

Documents

1 file

Issuer

Arcellx, Inc.

CIK 0001786205

Entity typeother

Related Parties

1
  • filerCIK 0001789632

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 9:32 PM ET
Size
6.7 KB